Screener
enGene Therapeutics Inc. ENGN Q2 2025 earnings
Reported June 12, 2025 · Before market open
EPS-$0.51Miss by $0.01
EPS estimate-$0.50
Next report
Date not yet announcedVersus estimates
Diluted EPS
FAQ
- When did enGene Therapeutics Inc. report Q2 2025 earnings?
- enGene Therapeutics Inc. (ENGN) reported Q2 2025 earnings on June 12, 2025 before market open.
- What were enGene Therapeutics Inc.'s Q2 2025 revenue and EPS?
- enGene Therapeutics Inc. reported eps of $-0.51 for Q2 2025.
- Did enGene Therapeutics Inc. beat estimates in Q2 2025?
- EPS missed the consensus estimate of $-0.50 by $0.01.
- How did enGene Therapeutics Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 34.2% from $-0.38.
- Where can I find enGene Therapeutics Inc.'s Q2 2025 SEC filings?
- You can read the 8-K earnings release (0000950170-25-083444) and the 10-Q periodic report (0000950170-25-085143) directly on SEC EDGAR. The filing index links above go to sec.gov.
